Pharma Aids’ Q3 earnings decline due to pandemic

Due to an increase in expenses amid the Covid-19 pandemic, Pharma Aids has witnessed a slight decline in its Q3 (January-March) earnings. 

In a filing with Dhaka Stock Exchange on Sunday, the company said its earnings per share (EPS) was Tk 4.12, a 5.06 percent decline from Tk 4.34 a year earlier. 

Its EPS was Tk 12.17 for July 2020-March 2021 as against Tk 14.31 for the same period of the previous financial year. 

The company also said that its net operating cash flow per share (NOCFPS) was Tk 9.97 for July 2020-March 2021 as against Tk 11.94 for the previous financial year. 

Meanwhile, its net asset value (NAV) per share stood at Tk 89.45 as of March 31, 2021 and Tk 82.54 as of June 30, 2020.